Article Detail - JE Part A
Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (A57037) - R7 - Effective October 1, 2025
Date Posted: August 28, 2025
This Billing and Coding Article has been revised under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).
Effective Date: October 1, 2025
Summary of Changes:
Under ICD-10 Codes that Support Medical Necessity Group 1: Codes deleted E78.01 and E88.1. Added E78.010, E78.011, and E78.019. This revision is due to the Annual ICD-10-CM Update and will become effective on 10/1/2025.
Under CMS National Coverage Policy revised the following regulation: CMS Internet-Only Manual, Pub. 100-04, Medicare Claims Processing Manual, Chapter 16, §50.5 Jurisdiction of Laboratory Claims, §60.1.1 Independent Laboratory Specimen Drawing, §60.2 Travel Allowance. This revision is effective 10/1/2025.
Updated Associated Documents to remove Billing and Coding: MolDX: ApoE Genotype.
Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.
